GigaGen
Pre-clinicalDevelops recombinant polyclonal antibody therapies for infectious diseases and oncology using single-cell genomics.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $37M
About
Develops recombinant polyclonal antibody therapies for infectious diseases and oncology using single-cell genomics.
Biologics
Funding History
3Total raised:$37M
Series B$20MJul 15, 2020
Series A$15MMay 15, 2018
Seed$2MJun 15, 2015